COIOSDeep risk insights through multi-disciplinary research across the globe
city during daytime
Item confirms Peer-reviewed Added

RSV hospitalisations in older Brazilians rose after 2020, with 21-31% dying in hospital

Recorded hospitalisations for RSV among Brazilians aged 60 and over rose from under 1 to over 15 per 100,000 between 2013 and 2024, with the sharpest rise after 2020.

Brazil's national influenza surveillance system recorded 4,636 RSV-associated hospitalisations in adults aged 60 and over between 2013 and 2024. Recorded rates rose from under 1 per 100,000 in 2013 to over 15 per 100,000 in 2024, the sharpest rise after 2020. In-hospital case fatality stayed between 21% and 31%, highest above age 80, and almost a third of cases needed intensive care.

Why it is interesting: Quantifies RSV deaths in older Brazilian adults, though the rise tracks expanded testing as much as incidence.

Source
PLOS One, 18 September 2026
Paper
Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024)
Authors
de Veras BMG, Michelin L, Croda J, Berra TZ, Pires-Matheus G, Sampietri I et al.
DOI
10.1371/journal.pone.0357303
Type
Peer-reviewed article
Design
Retrospective analysis of national SARI surveillance records (SIVEP-Gripe), 4,636 RSV-associated hospitalisations in adults aged 60+, Brazil, 2013-2024
Verdict
Confirms prior evidence
Driver
Infection and pandemics
Free full text
Free to read at the publisher
Attention
1 citation (Crossref) · as of 2026-10-09
Abstract — the authors' own words, CC BY

Background

Globally, respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness in adults aged ≥60 years. Risk increases with advancing age and comorbidities, particularly cardiopulmonary disease and diabetes. RSV disease burden in adults is often underestimated due to non-specific presentation and limited testing. In Brazil, RSV is a recognized driver of hospitalizations and deaths in older adults, yet comprehensive epidemiological data remain scarce. Here, we describe RSV-associated severe acute respiratory infection (SARI) hospitalizations among adults aged ≥60 years in Brazil between 2013 and 2024. Methods

We retrospectively analyzed RSV-associated SARI hospitalizations reported to the national Influenza Epidemiological Surveillance Information System -Gripe. Outcomes included hospitalization frequency, in-hospital mortality, case fatality rates (CFRs), seasonality, healthcare resource utilization, and comorbidities. Results

Between 2013 and 2024, 4,636 RSV-related hospitalizations occurred in adults aged ≥60 years, increasing sharply after the COVID-19 pandemic (2020-2024). Hospitalization rates increased from 15 per 100,000 in 2024. Women accounted for most cases (59%), and hospitalizations were concentrated in the South and Southeast regions partly due to test availability. In-hospital mortality increased over time, with mean rates nearly fivefold higher post-pandemic than pre-pandemic. CFRs remained consistently high (21-31%), particularly in adults aged ≥80 years. The mean length of hospital stay was 12.9 days. Almost one-third of cases required intensive care unit admission, of whom more than two-thirds needed ventilatory support. Comorbidities were present in 71% of cases, most commonly cardiovascular (65%) and diabetes (33%)were strongly associated with increased mortality and healthcare resource utilization. Conclusions

RSV poses a substantial and increasing burden among Brazilian adults aged ≥60 years, with a high CFR, prolonged hospitalizations, and intensive healthcare resource utilization. These findings highlight the need to strengthen RSV surveillance and discuss vaccination strategies for adults aged older in Brazil.

Other drivers in Behavioural science